Analytical Data
-
基因名
AMDHD1
- Application
-
别名
AMDHD1; HMFT1272; Probable imidazolonepropionase; EC 3.5.2.7
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96NU7
-
表达区间
1-426aa
-
氨基酸序列
MASGHSLLLENAQQVVLVCARGERFLARDALRSLAVLEGASLVVGKDGFIKAIGPADVIQRQFSGETFEEIIDCSGKCILPGLVDAHTHPVWAGERVHEFAMKLAGATYMEIHQAGGGIHFTVERTRQATEEELFRSLQQRLQCMMRAGTTLVECKSGYGLDLETELKMLRVIERARRELDIGISATYCGAHSVPKGKTATEAADDIINNHLPKLKELGRNGEIHVDNIDVFCEKGVFDLDSTRRILQRGKDIGLQINFHGDELHPMKAAELGAELGAQAISHLEEVSDEGIVAMATARCSAILLPTTAYMLRLKQPRARKMLDEGVIVALGSDFNPNAYCFSMPMVMHLACVNMRMSMPEALAAATINAAYALGKSHTHGSLEVGKQGDLIIINSSRWEHLIYQFGGHHELIEYVIAKGKLIYKT
-
分子量
62.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AMDHD1, or "N-acyl amino acid hydrolase 1," is an enzyme that plays a crucial role in the metabolism of N-acyl amino acids, which are important signaling molecules involved in various physiological processes. Research on AMDHD1 has garnered attention due to its potential implications in metabolic disorders, neurological conditions, and inflammatory responses. Dysregulation of N-acyl amino acid levels has been linked to numerous health issues, making AMDHD1 a promising target for therapeutic interventions. Understanding the structure, function, and regulatory mechanisms of AMDHD1 can provide insights into its biological role and pave the way for novel treatments. Studies have shown that this enzyme is capable of hydrolyzing a wide range of N-acyl amino acids, thereby influencing their bioavailability and activity. Recent advancements in protein engineering and purification techniques have enabled researchers to produce recombinant AMDHD1 for detailed biochemical characterization and functional assays. By elucidating the enzymatic pathways involving AMDHD1, scientists hope to uncover its contributions to human health and disease, ultimately leading to the development of innovative strategies for the management of metabolic and neurodegenerative disorders.
